Articles by David C. Henderson, MD

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled,...

Nasser, Azmi F.; Henderson, David C.; Fava, Maurizio; More

Journal of Clinical Psychopharmacology. 36(2):130-140, April 2016.

A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in Schizophrenia

Evins, A. Eden; Cather, Corinne; Culhane, Melissa A.; More

Journal of Clinical Psychopharmacology. 27(4):380-386, August 2007.

A Double-blind Placebo-Controlled Trial of Bupropion Sustained-Release for Smoking Cessation in Schizophrenia

Evins, A. Eden; Cather, Corinne; Deckersbach, Thilo; More

Journal of Clinical Psychopharmacology. 25(3):218-225, June 2005.